Rivaroxaban The Next Big Thing in Anticoagulant Market Manufactured by Pinnacle Life Sciences

1. Rivaroxaban: The Next Big Thing in Anticoagulant Market Manufactured by Pinnacle Life Sciences

2. About Pinnacle Lifescience • Pinnacle Life Science is a 100% subsidiary of India’s most trusted pharmaceutical company Aarti Drugs Ltd (ADL) and forms part of $ 1.5 billion conglomerate of the esteemed Aarti Group of Industries. • With 35 years of healthcare commitment through Aarti Drugs, Pinnacle has made its presence in nearly 90+ countries. Treading carefully on the path of efficient healthcare, the state-of-the-art manufacturing facility is designed to produce formulations that meet international quality standards and stringent regulatory compliances to trade beyond borders. • With significant expansion in R&D, Manufacturing & Marketing capabilities, we are poised for an accelerated growth.

3. Rivaroxaban: The Next Big Thing in Anticoagulant Market Manufactured by Pinnacle Life Sciences • Medicines called anticoagulants aid in the prevention of blood clots. People who have a high risk of blood clots might suffer the risk of strokes and heart attacks. • A blood clot is like a seal that prevents wounds from bleeding. While they help halt the excessive blood outflow, they can hinder veins and stop blood streaming to organs like the mind, heart or lungs. • By interrupting the process by which blood clots form, anticoagulants work. Despite not making the blood thinner, these medications are also termed “blood-thinning” medications. s. A common anticoagulant that the medical field sees regularly is rivaroxaban.

4. What Is Rivaroxaban? • Rivaroxaban is a medication used to treat and prevent conditions related to blood clots in adults, children, and even infants. Specifically, it treats deep vein thrombosis (DVT), a blood clot that typically forms in the leg, and pulmonary embolism (PE), a blood clot that occurs in the lung. It can also help prevent DVT and PE from recurring after initial treatment in adults. • Pinnacle is a proud manufacturer of an extensive product line for acute and chronic diseases. Among other innovations, Pinnacle has embossed itself as a leading name among the rivaroxaban manufacturer. Rivaroxaban lowers the risk of strokes or deep blood clots in adults with atrial fibrillation, a heart condition characterized by an irregular heartbeat that can lead to blood clots forming in the body and potentially causing strokes.

5. What Sets Pinnacle Apart From Other Rivaroxaban Manufacturers? • As one Pinnacle has established itself as a leading manufacturer of anticoagulant drugs, including rivaroxaban and apixaban. With a focus on the CNS category, rivaroxaban is highly effective in preventing blood clots related to deep vein thrombosis (DVT) and pulmonary embolism. Pinnacle’s research facility is dedicated to analyzing the formulation and production of rivaroxaban, ensuring that all related processes are separate from other drug development procedures. • Efficient Quality Management System : Pinnacle’s commitment to quality is evident in its Pharmaceutical Quality Management System (QMS), which ensures that all manufacturing processes adhere to international standards. As a CDMO pharma company in India, Pinnacle continually assesses its operations to improve efficiency and ensure compliance with quality standards.

6. What Sets Pinnacle Apart From Other Rivaroxaban Manufacturers? • Health and Safety Standards : Meeting health and safety standards is critical in the pharmaceutical industry, and Pinnacle prioritizes this aspect of its operations. Adhering to health and safety standards ensures the safety and well-being of consumers and maintains the quality and efficacy of drugs. Pinnacle’s guidelines assure that its products are not only of high quality but also cost-effective. • Research and Development : Pinnacle’s commitment to research and development has led to cutting-edge advancements in drug delivery technologies. As a pharma contract manufacturer in India, Pinnacle uses advanced technologies and innovation in biomedical science to improve the lives of countless individuals. Its focus on innovation has helped it earn a place among the top CDMO companies in India and establish itself as a renowned name in the industry.

7. Conclusion • As one of the leading CDMO companies in India, Pinnacle dedicates itself to developing healthcare innovations. At Pinnacle, we’re committed to ethical practices for sustainable business success. • Integrity, ethics, and commitment are the core values that drive Pinnacle as a globally acclaimed metformin manufacturer. • Our dedication to research and development has enabled us to achieve unparalleled excellence in biomedical science innovation. Connect with Pinnacle to explore our range of products.

8. Contact Us Address: Mahendra Industrial Estate, Ground Floor, Plot No. 109D, Road No 29, Sion(E) Mumbai-400022, India. Phone No: +91 (22) – 24019025 Email: export.pinnacle@aartidrugs.com Site: www.pinnaclelifescience.com